Brammer invests in commercial-ready gene therapies – OutSourcing-Pharma.com
|
Brammer invests in commercial-ready gene therapies
OutSourcing-Pharma.com The contract development and manufacturing organization (CDMO) said the site offers process development, clinical phase, and current Good Manufacturing Practices (cGMP) services for cell and gene therapies. “We are delighted to add an experienced … |
